Orchard Therapeutics
General Information
Identification Code: 181526639749-13
Website: [object Object]
Entity Form: plc
Registration Category: Companies & groups
Registration Date: 9/29/2020
Last Update: 8/21/2023
EP Accredited Number: 0
Mission & Interests
Goals: Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
- Research and innovation
- Trans-European Networks
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: EU pharma strategy
OMP legislation
ATMP legislation
Health Technology Assessment
Cross border directive
Social Security legislation
Communication Activities: Cross border healthcare - all rare disease related policies - European Reference Networks, - EU research agenda - new born screening - real world evidence
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 245 Hammersmith Road
Post Code: W6 8PW
City: London
Country: UNITED KINGDOM
Phone: [object Object]
EU Office
Address: 245 Hammersmith Road
Post Code: W6 8PW
City: London
Country: UNITED KINGDOM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 1
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.10000000149011612
Structure
Structure Type: Structure
Is Member Of: N/A
Organisation Members: ARM - Alliance for Regenerative Medicine
EUCOPE